Lenvima (lenvatinib) is a kinase inhibitor used to treat certain types of cancer. Kinase inhibitors are enzyme inhibitors that block the action of one or more protein kinases which interfere with the growth and spread of cancer cells in the body.
Uses of Lenvima
Lenvima is used to treat thyroid cancer [1]. It is usually administered after radioactive iodine fails to yield any improvement in one’s condition.
Lenvima is used together with everolimus (Afinitor) to treat advanced kidney cancer in people who have received one treatment course with another cancer medicine.
Lenvima is combined with pembrolizumab (Keytruda) to treat advanced kidney cancer that has spread to other parts of the body (metastatic), or cannot be removed with surgery.
Lenvima is also used together with Keytruda to treat a certain type of endometrial cancer [2] (a type of uterine cancer) that has progressed and cannot be removed with surgery or radiation.
Lenvima is also used to treat liver cancer that cannot be removed with surgery.
With the right combination, Lenvima can be used to treat several types of cancer. It is important that you get your prescription from a medical practitioner, after proper diagnosis has been made.